Sponsors (48)
Want the plain-English version? I'll explain what this bill does.
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Amends section 1861 of the Social Security Act by (1) adding Alpha-1 Antitrypsin Deficiency Disorder treatment to subsection (s)(2) as a new subparagraph (KK) and (2) adding a new definitional subsection (nnn) that defines 'Alpha-1 Antitrypsin Deficiency Disorder treatment' and related terms (applicable provider, home, augmentation therapy, qualified home infusion therapy supplier) and specifies beneficiary eligibility criteria.
Adds a new subsection (aa) to section 1834 of the Social Security Act establishing a payment system under which the Secretary makes payment under the title to a qualified home infusion therapy supplier for intravenous administration kits and up to 2 hours of nursing services in coordination with augmentation therapy for Alpha-1 Antitrypsin Deficiency Disorder treatment.
Makes conforming edits to section 1833(a)(1) of the Social Security Act by striking specified text and inserting specified text (text to be struck/inserted is shown as placeholders in the section).
Makes a conforming amendment to the first sentence of section 1842(b)(6) by striking specified text and inserting specified text (the amendment text is provided as placeholders).
Expands Medicare to cover at‑home treatment for Alpha‑1 Antitrypsin Deficiency when augmentation therapy is given by qualified home infusion therapy suppliers. It spells out who is eligible, what the therapy includes, and which providers can deliver it.
Medicare must pay for intravenous administration kits and up to 2 hours of nursing services tied to the therapy. It updates related Medicare payment and home health rules so the benefit works smoothly. The changes apply to items and services furnished on or after January 1, 2027.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced March 25, 2025 by Maria Elvira Salazar · Last progress March 25, 2025